PT1981862E - Compostos relacionados com lantionina para o tratamento de doenças inflamatórias - Google Patents
Compostos relacionados com lantionina para o tratamento de doenças inflamatórias Download PDFInfo
- Publication number
- PT1981862E PT1981862E PT07710015T PT07710015T PT1981862E PT 1981862 E PT1981862 E PT 1981862E PT 07710015 T PT07710015 T PT 07710015T PT 07710015 T PT07710015 T PT 07710015T PT 1981862 E PT1981862 E PT 1981862E
- Authority
- PT
- Portugal
- Prior art keywords
- lanthionine
- compounds
- derivatives
- treatment
- provides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/12—1,4-Thiazines; Hydrogenated 1,4-thiazines not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75725206P | 2006-01-09 | 2006-01-09 | |
| US78179406P | 2006-03-13 | 2006-03-13 | |
| US80414906P | 2006-06-07 | 2006-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1981862E true PT1981862E (pt) | 2011-06-01 |
Family
ID=38051848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT07710015T PT1981862E (pt) | 2006-01-09 | 2007-01-09 | Compostos relacionados com lantionina para o tratamento de doenças inflamatórias |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US7683055B2 (pt) |
| EP (1) | EP1981862B1 (pt) |
| JP (1) | JP5367377B2 (pt) |
| AT (1) | ATE500236T1 (pt) |
| AU (1) | AU2007204757B2 (pt) |
| CA (1) | CA2636042C (pt) |
| DE (1) | DE602007012833D1 (pt) |
| DK (1) | DK1981862T3 (pt) |
| PT (1) | PT1981862E (pt) |
| WO (1) | WO2007082208A2 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305834A1 (en) * | 2009-10-02 | 2011-04-06 | Advanced Practical Diagnostics N.V. | Haplotype of KATIII gene |
| MX2012007508A (es) * | 2009-12-28 | 2012-08-01 | Ajinotomo Co Inc | Derivados de lantionina. |
| EP2567225B1 (en) * | 2010-05-04 | 2019-10-02 | Virginia Tech Intellectual Properties, Inc. | Lanthionine synthetase component c-like proteins as molecular targets for preventing and treating diseases and disorders |
| US20130209366A1 (en) * | 2010-08-24 | 2013-08-15 | Oklahoma Medical Research Foundation | Glutathione-Lanthionine Compounds and Methods Related Thereto |
| CN102670796A (zh) * | 2012-05-22 | 2012-09-19 | 广西天天乐药业股份有限公司 | 一种治疗脾胃虚弱的中药及其制备方法 |
| US11084836B2 (en) * | 2016-02-26 | 2021-08-10 | The University Of Toledo | Compositions useful in therapy of autophagy-related pathologies, and methods of making and using the same |
| US10882831B2 (en) * | 2017-02-23 | 2021-01-05 | The University Of Toledo | Compositions useful in therapy of autophagy-related pathologies, and methods of making and using the same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2283186A (en) * | 1942-05-19 | Thiazane-j | ||
| US6025395A (en) | 1994-04-15 | 2000-02-15 | Duke University | Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders |
| EA006654B1 (ru) * | 2001-01-16 | 2006-02-24 | Женсет С. А. | Лечение нарушений центральной нервной системы с использованием антагонистов оксидазы d-аминокислот и d-аспартатоксидазы |
| US20030185754A1 (en) | 2001-01-16 | 2003-10-02 | Genset, S.A. | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
| US20030166554A1 (en) * | 2001-01-16 | 2003-09-04 | Genset, S.A. | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists |
-
2007
- 2007-01-09 AT AT07710015T patent/ATE500236T1/de active
- 2007-01-09 JP JP2008549685A patent/JP5367377B2/ja not_active Expired - Fee Related
- 2007-01-09 PT PT07710015T patent/PT1981862E/pt unknown
- 2007-01-09 CA CA2636042A patent/CA2636042C/en not_active Expired - Fee Related
- 2007-01-09 DK DK07710015.4T patent/DK1981862T3/da active
- 2007-01-09 US US11/621,469 patent/US7683055B2/en not_active Expired - Fee Related
- 2007-01-09 DE DE602007012833T patent/DE602007012833D1/de active Active
- 2007-01-09 EP EP07710015A patent/EP1981862B1/en not_active Not-in-force
- 2007-01-09 WO PCT/US2007/060277 patent/WO2007082208A2/en active Application Filing
- 2007-01-09 AU AU2007204757A patent/AU2007204757B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007204757A1 (en) | 2007-07-19 |
| US20070197515A1 (en) | 2007-08-23 |
| AU2007204757B2 (en) | 2012-09-06 |
| US7683055B2 (en) | 2010-03-23 |
| CA2636042C (en) | 2014-10-14 |
| DK1981862T3 (da) | 2011-06-14 |
| WO2007082208A2 (en) | 2007-07-19 |
| JP2009522377A (ja) | 2009-06-11 |
| WO2007082208A3 (en) | 2007-09-13 |
| ATE500236T1 (de) | 2011-03-15 |
| DE602007012833D1 (de) | 2011-04-14 |
| EP1981862B1 (en) | 2011-03-02 |
| EP1981862A2 (en) | 2008-10-22 |
| CA2636042A1 (en) | 2007-07-19 |
| JP5367377B2 (ja) | 2013-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA95644C2 (ru) | Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний | |
| TW200612892A (en) | Novel compounds | |
| IN2012DN01233A (pt) | ||
| PH12015501964B1 (en) | Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c | |
| TW200732296A (en) | Novel compounds | |
| TW200745003A (en) | Novel compounds | |
| IN2012DN00971A (pt) | ||
| TW200630336A (en) | Novel compounds | |
| MX2010009752A (es) | Compuestos de oxadiazoantraceno para el tratamiento de diabetes. | |
| TW200621690A (en) | Novel compounds | |
| UA103915C2 (ru) | Твердая лекарственная форма, которая содержит линаглиптин и ингибитор sglt2, и ее применение | |
| WO2011082273A3 (en) | Substituted pyrrolo-aminopyrimidine compounds | |
| WO2007076085A3 (en) | Fused pyrimidones and thiopyrimidones, and uses thereof | |
| WO2011082270A3 (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
| WO2007066336A3 (en) | Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof | |
| MX2011010923A (es) | Derivado de pirrolopiridina condensado. | |
| WO2011082267A3 (en) | Substituted triazolo-pyrazine compounds | |
| TW200745122A (en) | New compounds I | |
| UA98804C2 (ru) | Катехоламиновые производные и фармацевтическая композиция на их основе | |
| UA103930C2 (ru) | Соединения и композиция для лечения паразитарных болезней | |
| WO2008061724A3 (en) | Compositions comprising carnosic acid 12-methylether | |
| PT1981862E (pt) | Compostos relacionados com lantionina para o tratamento de doenças inflamatórias | |
| MX2019012939A (es) | Formulaciones que contienen linaclotida para administracion oral. | |
| WO2007066337A3 (en) | Jasmonate derivatives, pharmaceutical compositions and methods of use thereof | |
| GB0611907D0 (en) | Compounds |